Results 101 to 110 of about 2,365,753 (128)

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node. [PDF]

Orphanet J Rare Dis
Mantoan Ritter L, Annear NMP, Baple EL, Ben-Chaabane LY, Bodi I, Brosson L, Cadwgan JE, Coslett B, Crosby AH, Davies DM, Daykin N, Dedeurwaerdere S, Dühring Fenger C, Dunlop EA, Elmslie FV, Girodengo M, Hambleton S, Jansen AC, Johnson SR, Kearley KC, Kingswood JC, Laaniste L, Lachlan K, Latchford A, Madsen RR, Mansour S, Mihaylov SR, Muhammed L, Oliver C, Pepper T, Rawlins LE, Schim van der Loeff I, Siddiqui A, Takhar P, Tatton-Brown K, Tee AR, Tibarewal P, Tye C, Ultanir SK, Vanhaesebroeck B, Zare B, Pal DK, Bateman JM.   +42 more
europepmc   +1 more source

Spatial transcriptomics profiling of gallbladder adenocarcinoma: a detailed two-case study of progression from precursor lesions to cancer. [PDF]

BMC Cancer
Pirenne S, Manzano-Núñez F, Loriot A, Cordi S, Desmet L, Aydin S, Hubert C, Toffoli S, Limaye N, Sempoux C, Komuta M, Gatto L, Lemaigre FP.   +12 more
europepmc   +1 more source

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. [PDF]

Antioxidants (Basel)
Haesen S, Jager MM, Brillouet A, de Laat I, Vastmans L, Verghote E, Delaet A, D'Haese S, Hamad I, Kleinewietfeld M, Mebis J, Mullens W, Lambrichts I, Wolfs E, Deluyker D, Bito V.   +15 more
europepmc   +1 more source

Paramagnetic susceptibility measured by magnetic resonance imaging as an in vivo biomarker for iron pathology in epilepsy. [PDF]

Sci Adv
Li Z, Liu Q, Xu T, Zhang M, Li L, Chen Z, Tang Y, Jiang L, Lu Y, Yan F, Zhang Y, Xu J, Wei H.   +12 more
europepmc   +1 more source

The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis. [PDF]

Front Immunol
Calderon-Espinosa E, De Ridder K, Benoot T, Jansen Y, Vanhonacker D, Heestermans R, De Becker A, Van Riet I, Decoster L, Goyvaerts C.   +9 more
europepmc   +1 more source

PI3K and MAPK Signaling Nodes Serve as Divergent Drivers of Phenotypic Plasticity in Cancer-Associated Fibroblasts in Colorectal Cancer. [PDF]

Cancer Res
Xia Z, De Vuyst F, Ernst S, Suwal U, Vander Cruyssen A, Rappu P, Heino J, Dedeyne S, Ceelen W, Craciun L, Demetter P, Hendrix A, De Wever O.   +12 more
europepmc   +1 more source

Updates in clinical trial-explored chemopreventive agents for cutaneous melanoma: mechanisms affecting melanocytes. [PDF]

Melanoma Manag
Ghajar-Rahimi G, Yusuf N.
europepmc   +1 more source

The consequences of the new European reclassification of non-invasive brain stimulation devices and the medical device regulations pose an existential threat to research and treatment: An invited opinion paper. [PDF]

Clin Neurophysiol
Antal A, Ganho-Ávila A, Assecondi S, Barbour T, Bjekić J, Blumberger DM, Bolognini N, Brunelin J, Chanes L, Dale M, Dubbioso R, D'Urso G, Filipcic I, Filipović SR, Hirnstein M, Konings F, Langguth B, Leocani L, Sorkhabi MM, Mulder M, Nikander M, Nowak R, Oliviero A, Onarheim B, O'Shea J, Pallanti S, Rachid F, Rajão-Saraiva J, Rossi S, Sack AT, Sauvaget A, van der Scheer R, Schellhorn K, Soria-Frisch A, Szekely D, Tankisi H, Cj Taylor P, Tendolkar I, Uusitalo S, Baeken C.   +39 more
europepmc   +1 more source

The COMFORTage project: study protocol for the integration of multiple sources towards personalised preventions at Ace Alzheimer Center Barcelona. [PDF]

Front Digit Health
Valero S, Miguel A, Blazquez-Folch J, Calm B, Alegret M, Solivar A, Manias G, Antoniades A, Angelova N, Psimaris D, Segkouli S, Morera A, Tantinya N, Rosende-Roca M, Cano A, Fernández MV, Sanz-Cartagena P, Gurruchaga MJ, Tárraga L, Boada M, Ruiz A, Marquié M, and COMFORTage Consortium.   +22 more
europepmc   +1 more source